Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Blute

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Urology|October 5, 2001
Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4W K Lau, M L Blute, D G Bostwick, et al.
The Journal of Urology|February 18, 1999
Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancerC L Amling, S E Lerner, S K Martin, et al.
The Journal of Urology|July 1, 1996
Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomyS E Lerner, M L Blute, E J Bergstralh, et al.
Mayo Clinic Proceedings|May 15, 1998
Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practiceC L Amling, M L Blute, S E Lerner, et al.
The Journal of Urology|October 1, 1987
Bilateral Wilms tumorM L Blute, P P Kelalis, K P Offord, et al.
Urology|August 1, 1993
Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristicsD A Guthman, T M Wilson, M L Blute, et al.
Urology|June 4, 1998
A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trialT R Larson, M L Blute, R C Bruskewitz, et al.
AJR. American Journal of Roentgenology|October 24, 2003
Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablationM A Farrell, J W Charboneau, M R Callstrom, et al.
Mayo Clinic Proceedings|May 1, 1992
Transurethral microwave thermotherapy for prostatism: early Mayo Foundation experienceM L Blute, K M Tomera, D K Hellerstein, et al.
Cancer|April 3, 1999
Predictors of cancer progression in T1a prostate adenocarcinomaL Cheng, E J Bergstralh, B G Scherer, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Urology|October 5, 2001
Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4W K Lau, M L Blute, D G Bostwick, et al.
The Journal of Urology|February 18, 1999
Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancerC L Amling, S E Lerner, S K Martin, et al.
The Journal of Urology|July 1, 1996
Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomyS E Lerner, M L Blute, E J Bergstralh, et al.
Mayo Clinic Proceedings|May 15, 1998
Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practiceC L Amling, M L Blute, S E Lerner, et al.
The Journal of Urology|October 1, 1987
Bilateral Wilms tumorM L Blute, P P Kelalis, K P Offord, et al.
Urology|August 1, 1993
Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristicsD A Guthman, T M Wilson, M L Blute, et al.
Urology|June 4, 1998
A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trialT R Larson, M L Blute, R C Bruskewitz, et al.
AJR. American Journal of Roentgenology|October 24, 2003
Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablationM A Farrell, J W Charboneau, M R Callstrom, et al.
Mayo Clinic Proceedings|May 1, 1992
Transurethral microwave thermotherapy for prostatism: early Mayo Foundation experienceM L Blute, K M Tomera, D K Hellerstein, et al.
Cancer|April 3, 1999
Predictors of cancer progression in T1a prostate adenocarcinomaL Cheng, E J Bergstralh, B G Scherer, et al.
Pageof 12